- Marketwired•3 years agoCytomedix Announces Final Payment Decision From the Centers for Medicare & Medicaid Services for the AutoloGel(TM) System
Cytomedix, Inc. , a leading developer of biologically active regenerative therapies, announced today that the Centers for Medicare & Medicaid Services has issued final Medicare payment regulations for ...
- Marketwired•3 years agoCytomedix Reports Third Quarter 2013 Financial Results and Begins Supplying AutoloGel to Treat Medicare Patients
Cytomedix, Inc. , a leading developer of biologically active regenerative therapies, today reported financial results for the third quarter of 2013 and announced the initiation of AutoloGel sales to treat ...
We're sorry this is all we were able to find about this topic.
. Currency in USD
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52wk Range||undefined - undefined|
|1y Target Est||N/A|
|P/E Ratio (ttm)||N/A|
|Avg Vol (3m)||N/A|
|Dividend & Yield||N/A (N/A)|